Denali Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell DNLI and other ETFs, options, and stocks.About DNLI
Denali Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates for neurodegenerative diseases. Its product pipeline includes LRRK2, RIPK1, TREM2, and Tau.
DNLI Key Statistics
Stock Snapshot
As of today, Denali Therapeutics(DNLI) shares are valued at $20.80. The company's market cap stands at 3.27B, with a P/E ratio of -6.95.
During the trading session on 2026-04-03, Denali Therapeutics(DNLI) shares reached a daily high of $20.80 and a low of $18.92. At a current price of $20.80, the stock is +9.9% higher than the low and still 0.0% under the high.
Trading volume for Denali Therapeutics(DNLI) stock has reached 1.63M, versus its average volume of 2.66M.
Over the past 52 weeks, Denali Therapeutics(DNLI) stock has traded between a high of $23.77 and a low of $10.57.
Over the past 52 weeks, Denali Therapeutics(DNLI) stock has traded between a high of $23.77 and a low of $10.57.
DNLI News
Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...
Analyst ratings
95%
of 19 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.